Status:

UNKNOWN

Prostate Interstitial Brachytherapy With I125 Implant With Target Dose Supplementation in the Tumor Volume Guided by TRINITY® PERINE 3D System

Lead Sponsor:

University Hospital, Grenoble

Collaborating Sponsors:

Clinical Investigation Centre for Innovative Technology Network

Koelis

Conditions:

Prostate Cancer

Eligibility:

MALE

18+ years

Phase:

NA

Brief Summary

The objective of the FOCUS-Boost project is to implant for the first time with a 3D ultrasound image fusion registration system (3D echo) implant of iodine 125 with precision in a target volume determ...

Detailed Description

The interstitial brachytherapy procedure for the prostate does not allow for a robust focal treatment to accurately deliver additional dose to the tumour volume. FOCUS BOOST allows the precise implant...

Eligibility Criteria

Inclusion

  • At least 18 years
  • Patient to be treated with brachytherapy
  • Patient with low or favorable intermediate risk prostate adenocarcinoma ISUP 1 and 2, G6 (3+3) or G7 (3+4)
  • Life expectancy of more than 10 years
  • PSA (prostate-specific antigen) \< 15 ng/ml
  • cT1c or cT2a or cT2b
  • Prostate volume ≤ 60 cc
  • ECOG Performance status 0-2
  • Patient is affiliated to a health insurance system
  • Patient who has signed consent form

Exclusion

  • Patient with urinary function disorders IPSS\> 14
  • Prostate volume \> 60cc.
  • Gleason 7(4+3) or Gleason score ≥8
  • PSA ≥ 15 ng/ml
  • Patient with metastases
  • Hormone therapy with antiandrogen or LHRH analogue
  • History of abdominopelvic irradiation
  • Inflammatory digestive disease (haemorrhagic rectocolitis, Crohn's disease)
  • Interventional study in progress that may interfere with the present study
  • Protected persons (patient concerned by articles L1121-5, L1121-6, L1121-8 of the French public health code)

Key Trial Info

Start Date :

April 4 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2025

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT05322356

Start Date

April 4 2023

End Date

June 1 2025

Last Update

November 29 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Isabelle Boudry

Grenoble, France, 38043